Picture of Gensight Biologics SA logo

SIGHT — Gensight Biologics SA News Story

0.000.00%
fr flag iconLast trade - 00:00
HealthcareHighly SpeculativeMicro CapMomentum Trap

Brief: Gensight Biologics To Submit LUMEVOQ For European Authorization In September

July 21 (Reuters) - GENSIGHT BIOLOGICS SA  SIGHT.PA :
    * LUMEVOQ ON TRACK FOR SEPTEMBER 2020 SUBMISSION IN EUROPE

Source text for Eikon:  ID:nBw1Wl0bCa 
Further company coverage:  SIGHT.PA 

 (Gdansk Newsroom)
 ((gdansk.newsroom@thomsonreuters.com; +48 58 778 51 10;))

Recent news on Gensight Biologics SA

See all news